Diversified Trust Co Buys 2,775 Shares of STERIS plc $STE

Diversified Trust Co boosted its stake in STERIS plc (NYSE:STE – Free Report) by 64.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,084 shares of the medical equipment provider’s stock after acquiring an additional 2,775 shares during the period. Diversified Trust Co’s holdings in STERIS were worth $1,488,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of STE. Western Wealth Management LLC purchased a new position in shares of STERIS during the first quarter worth about $25,000. Compass Financial Management LLC acquired a new stake in shares of STERIS during the third quarter worth about $25,000. Elevation Wealth Partners LLC increased its position in shares of STERIS by 1,130.0% during the second quarter. Elevation Wealth Partners LLC now owns 123 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 113 shares in the last quarter. Trust Co. of Vermont purchased a new stake in shares of STERIS in the 2nd quarter valued at about $41,000. Finally, Community Financial Services Group LLC lifted its holdings in shares of STERIS by 50.0% in the 3rd quarter. Community Financial Services Group LLC now owns 216 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 72 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

Insider Activity at STERIS

In other STERIS news, CFO Karen Burton sold 5,880 shares of STERIS stock in a transaction that occurred on Wednesday, November 11th. The stock was sold at an average price of $255.62, for a total value of $1,503,045.60. Following the transaction, the chief financial officer directly owned 12,956 shares in the company, valued at approximately $3,311,812.72. This trade represents a 31.22% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Mohsen Sohi sold 4,893 shares of the business’s stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $253.22, for a total value of $1,239,005.46. Following the completion of the transaction, the director directly owned 24,305 shares in the company, valued at approximately $6,154,512.10. The trade was a 16.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 1.12% of the company’s stock.

STERIS Price Performance

Shares of STE opened at $263.76 on Monday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.44 and a current ratio of 2.05. STERIS plc has a fifty-two week low of $195.14 and a fifty-two week high of $269.44. The firm has a 50-day simple moving average of $223.28 and a 200-day simple moving average of $224.61. The company has a market capitalization of $25.61 billion, a price-to-earnings ratio of 31.29 and a beta of 0.86.

STERIS (NYSE:STE – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The medical equipment provider reported $2.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.68 by $0.26. The firm had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.56 billion. STERIS had a return on equity of 14.80% and a net margin of 13.41%. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.47 EPS. On average, equities research analysts anticipate that STERIS plc will post 11.46 earnings per share for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Tuesday, November 17th will be given a dividend of $0.69 per share. This represents a $2.76 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Tuesday, November 17th. STERIS’s dividend payout ratio (DPR) is presently 32.74%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on STE. Morgan Stanley raised STERIS from an “overweight” rating to a “buy” rating in a research report on Friday. Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Weiss Ratings raised STERIS from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, November 9th. KeyCorp boosted their price objective on STERIS from $269.00 to $284.00 and gave the company an “overweight” rating in a research note on Friday, November 6th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $275.00 price objective (up from $270.00) on shares of STERIS in a research note on Friday, August 7th. Five research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $283.50.

View Our Latest Stock Analysis on STE

STERIS Profile

(Free Report)

STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.

Further Reading

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.